Torchio Federica, Garatti Andrea, Ronco Daniele, Matteucci Matteo, Massimi Giulio, Lorusso Roberto
Department of Cardiothoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, The Netherlands.
Department of Medicine and Surgery, Circolo Hospital, University of Insubria, Varese, Italy.
Ann Cardiothorac Surg. 2022 May;11(3):290-298. doi: 10.21037/acs-2022-ami-25.
Left ventricular pseudoaneurysm (LVP) is a very rare, but potentially lethal mechanical complication of acute myocardial infarction (AMI). Despite representing a unique subset of cardiac rupture, it presents peculiar features that distinguish it from both ventricular free-wall rupture (FWR) and ventricular true aneurysm. LVP occurs in less than 0.5% of patients affected by AMI. However, LVP is generally burdened by high mortality, often related to false cavity rupture, leading to catastrophic and often irreversible consequences. The risk of rupture is inversely proportional to the timing from AMI onset, which also determines both the classification of LVP and drives the indication for treatment. Despite the lack of a current consensus on LVP management, urgent surgery is the treatment of choice for LVPs occurring within 3 months from AMI, especially if larger than 3 cm in diameter. A matter of debate, however, is represented by chronic LVPs, especially because the risk of rupture decreases progressively as time passes and left ventricular (LV) false cavity stabilizes. Surgical mortality rate remains not negligible (more than 20%), but these suboptimal results may be considered acceptable, especially considering the lethality associated with the occurrence of pseudoaneurysm rupture. Diagnostic workup is essential for anatomical characterization of LV rupture, which is mandatory to guide the decision on surgical approach and technique for pseudoaneurysm repair. Finally, for a subset of patients with anterior LVP and a well-defined fibrotic neck, and deemed at excessively high surgical risk, percutaneous closure of the cavity has been described with encouraging results.
左心室假性动脉瘤(LVP)是急性心肌梗死(AMI)非常罕见但可能致命的机械性并发症。尽管它是心脏破裂的一个独特亚型,但具有一些独特特征,使其有别于心室游离壁破裂(FWR)和心室真性动脉瘤。LVP在AMI患者中的发生率不到0.5%。然而,LVP通常死亡率较高,常与假性腔破裂有关,会导致灾难性且往往不可逆转的后果。破裂风险与AMI发病后的时间成反比,这也决定了LVP的分类并驱动治疗指征。尽管目前对于LVP的治疗缺乏共识,但对于AMI发病3个月内发生的LVP,尤其是直径大于3 cm的,紧急手术是首选治疗方法。然而,慢性LVP存在争议,特别是因为随着时间推移和左心室(LV)假性腔稳定,破裂风险会逐渐降低。手术死亡率仍然不可忽视(超过20%),但考虑到假性动脉瘤破裂相关的致死性,这些不太理想的结果可能被认为是可以接受的。诊断检查对于LV破裂的解剖特征描述至关重要,这对于指导假性动脉瘤修复的手术入路和技术决策是必不可少的。最后,对于一部分前壁LVP且纤维性颈部明确、被认为手术风险过高的患者,经皮封堵腔隙已被报道并取得了令人鼓舞的结果。